US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
JPH10508744A
(ja)
|
1994-09-22 |
1998-09-02 |
クオドラント ホールディングス ケンブリッジ リミテッド |
運動競技の間の水分補給および栄養摂取の用途のための組成物ならびにその製造法
|
US6964771B1
(en)
*
|
1995-06-07 |
2005-11-15 |
Elan Drug Delivery Limited |
Method for stably incorporating substances within dry, foamed glass matrices
|
JP2014148555A
(ja)
*
|
1995-07-27 |
2014-08-21 |
Genentech Inc |
タンパク質の処方
|
US6685940B2
(en)
*
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
IL122910A
(en)
*
|
1995-07-27 |
2002-05-23 |
Genentech Inc |
Stable isotonic protein formulation that has undergone lyophilization
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
US5958455A
(en)
*
|
1996-02-09 |
1999-09-28 |
Quadrant Holdings Cambridge Ltd |
Oral solid dosage forms, methods of making same and compositions thereof
|
US5762961A
(en)
*
|
1996-02-09 |
1998-06-09 |
Quadrant Holdings Cambridge Ltd. |
Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
|
AUPN801296A0
(en)
*
|
1996-02-12 |
1996-03-07 |
Csl Limited |
Stabilised growth hormone formulation and method of preparation thereof
|
ATE227980T1
(de)
|
1996-03-28 |
2002-12-15 |
Takeda Chemical Industries Ltd |
Zubereitung mit verzögerter freisetzung und deren herstellung
|
US6632648B1
(en)
*
|
1996-05-14 |
2003-10-14 |
Elan Drug Delivery Limited |
Methods of terminal sterilization of fibrinogen
|
US5916582A
(en)
*
|
1996-07-03 |
1999-06-29 |
Alza Corporation |
Aqueous formulations of peptides
|
PL189402B1
(pl)
*
|
1996-07-03 |
2005-08-31 |
Alza Corp |
Niewodny preparat peptydowy, sposób wytwarzania niewodnego preparatu peptydowego i zastosowanie preparatu
|
US5932547A
(en)
*
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
US5861174A
(en)
*
|
1996-07-12 |
1999-01-19 |
University Technology Corporation |
Temperature sensitive gel for sustained delivery of protein drugs
|
US5981489A
(en)
*
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
US6468782B1
(en)
|
1996-12-05 |
2002-10-22 |
Quadrant Healthcare (Uk) Limited |
Methods of preserving prokaryotic cells and compositions obtained thereby
|
DE69719367T2
(de)
|
1996-12-20 |
2003-10-16 |
Takeda Chemical Industries Ltd |
Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
US6113947A
(en)
*
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6991790B1
(en)
|
1997-06-13 |
2006-01-31 |
Genentech, Inc. |
Antibody formulation
|
GEP20022707B
(en)
*
|
1997-07-18 |
2002-06-25 |
Infimed Inc Us |
Biodegrading Macromers for the Controlled Release of Biologically Active Substances
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
EP1071465A1
(de)
*
|
1998-03-18 |
2001-01-31 |
Ronai, Peter |
Amorphe gläser zur stabilisierung von empfindlichen produkten
|
AU3473999A
(en)
*
|
1998-04-03 |
1999-10-25 |
Chiron Corporation |
Injectable igf-formulations containing succinate as buffering agent
|
WO1999053943A2
(en)
*
|
1998-04-17 |
1999-10-28 |
Angiogenix, Incorporated |
Therapeutic angiogenic factors and methods for their use
|
US6284282B1
(en)
*
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
US6190701B1
(en)
|
1999-03-17 |
2001-02-20 |
Peter M. Ronai |
Composition and method for stable injectable liquids
|
GB9910975D0
(en)
*
|
1999-05-13 |
1999-07-14 |
Univ Strathclyde |
Rapid dehydration of proteins
|
US6566329B1
(en)
*
|
1999-06-28 |
2003-05-20 |
Novo Nordisk A/S |
Freeze-dried preparation of human growth hormone
|
US6102896A
(en)
*
|
1999-09-08 |
2000-08-15 |
Cambridge Biostability Limited |
Disposable injector device
|
US7651703B2
(en)
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US7582311B1
(en)
|
1999-10-15 |
2009-09-01 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
AU2001233180A1
(en)
*
|
2000-02-10 |
2001-08-20 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing a sustained release composition
|
AU5911101A
(en)
|
2000-04-19 |
2001-10-30 |
Genentech Inc |
Sustained release formulations
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
PT1280520E
(pt)
|
2000-05-10 |
2014-12-16 |
Novartis Ag |
Pós à base de fosfolípidos para administração de fármacos
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US6653062B1
(en)
*
|
2000-07-26 |
2003-11-25 |
Wisconsin Alumni Research Foundation |
Preservation and storage medium for biological materials
|
TWI283182B
(en)
|
2000-08-07 |
2007-07-01 |
Nektar Therapeutics |
Inhalable spray dried 4-helix bundle protein powders having minimized aggregation
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
DE60043459D1
(de)
*
|
2000-10-13 |
2010-01-14 |
Cambridge Biostability Ltd |
Pharmazeutische flüssige Suspensionen
|
US20040109827A1
(en)
*
|
2000-11-29 |
2004-06-10 |
Satomi Onoue |
Powdery preparations and proecss for producing the same
|
US20040022861A1
(en)
*
|
2001-01-30 |
2004-02-05 |
Williams Robert O. |
Process for production of nanoparticles and microparticles by spray freezing into liquid
|
DK1372729T3
(da)
*
|
2001-02-23 |
2009-06-22 |
Genentech Inc |
Nedbrydelige polymere til injektion
|
DK1397155T3
(en)
|
2001-06-21 |
2015-12-07 |
Genentech Inc |
Prolonged release formulation
|
GB0116074D0
(en)
*
|
2001-06-29 |
2001-08-22 |
Univ Strathclyde |
Nanoparticle structures
|
US7615234B2
(en)
*
|
2001-09-11 |
2009-11-10 |
Glide Pharmaceutical Technologies Limited |
Drug delivery technology
|
GB2379390B
(en)
*
|
2001-09-11 |
2005-01-26 |
Caretek Medical Ltd |
A novel drug delivery technology
|
TWI324518B
(en)
|
2001-12-19 |
2010-05-11 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US20030228681A1
(en)
*
|
2002-04-05 |
2003-12-11 |
Powerzyme, Inc. |
Analyte sensor
|
US20050175693A1
(en)
*
|
2002-05-09 |
2005-08-11 |
Peptron Co., Ltd |
Substained release formulation of protein and preparation method thereof
|
GB2421689B
(en)
|
2002-08-05 |
2007-03-07 |
Caretek Medical Ltd |
Drug delivery system
|
US7045552B2
(en)
*
|
2002-09-27 |
2006-05-16 |
Trimeris, Inc. |
Pharmaceutical composition for improved administration of HIV gp41-derived peptides, and its use in therapy
|
CN100444848C
(zh)
*
|
2002-09-27 |
2008-12-24 |
特里梅里斯公司 |
HIV gp41-衍生肽的改善用药的药物组合物
|
US7462365B2
(en)
|
2002-10-17 |
2008-12-09 |
Costantino Henry R |
Microencapsulation and sustained release of biologically active polypeptides
|
BR0317888A
(pt)
*
|
2002-12-31 |
2005-12-06 |
Altus Pharmaceuticals Inc |
Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
|
NZ571243A
(en)
*
|
2002-12-31 |
2010-04-30 |
Altus Pharmaceuticals Inc |
Complexes of protein crystals and ionic polymers comprising human growth hormone and protamine
|
US20040197413A1
(en)
*
|
2003-04-04 |
2004-10-07 |
Genteric, Inc. |
Spray dry coacervation systems and methods
|
DE10320609A1
(de)
*
|
2003-05-08 |
2004-12-02 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Sprühgefriergranulate mit verbesserter Homogenität der Eigenschaftsverteilung und Verfahren zu deren Herstellung
|
US7090433B2
(en)
*
|
2003-10-07 |
2006-08-15 |
Steve Searby |
Underground cable laying apparatus
|
US20050095320A1
(en)
*
|
2003-10-29 |
2005-05-05 |
Richard Botteri |
[An Isotonic Sports Drink for Female Athletes Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Nutrition During Execise and Competition]
|
US20050100636A1
(en)
*
|
2003-11-10 |
2005-05-12 |
Megan Botteri |
[A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
|
BRPI0418304A
(pt)
*
|
2004-01-07 |
2007-05-02 |
Trimeris Inc |
peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
CA2560981C
(en)
*
|
2004-04-15 |
2013-02-19 |
Steven G. Wright |
Polymer-based sustained release device
|
JP2007277094A
(ja)
*
|
2004-06-29 |
2007-10-25 |
Chemo Sero Therapeut Res Inst |
改変ダニ主要アレルゲン含有医薬組成物
|
US7133638B2
(en)
*
|
2004-11-18 |
2006-11-07 |
Xerox Corporation |
Scanning method and an image-processing device including the same
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
GB2422784A
(en)
*
|
2005-02-07 |
2006-08-09 |
Caretek Medical Ltd |
Disposable assembly comprising a needle or stylet
|
SI1865986T1
(sl)
*
|
2005-03-08 |
2016-05-31 |
Pfizer Products Inc. |
Sestavki protitelesa proti CTLA-4
|
CN100336557C
(zh)
*
|
2005-05-11 |
2007-09-12 |
北京双鹭药业股份有限公司 |
一种生长抑素的水溶液制剂、其制备方法及应用
|
CN100337684C
(zh)
*
|
2005-05-11 |
2007-09-19 |
北京双鹭药业股份有限公司 |
一种胸腺五肽的水溶液制剂、其制备方法及应用
|
CN100342909C
(zh)
*
|
2005-05-11 |
2007-10-17 |
北京双鹭药业股份有限公司 |
一种胸腺素α1的水溶液制剂、其制备方法及应用
|
GB0517688D0
(en)
*
|
2005-08-31 |
2005-10-05 |
Cambridge Biostability Ltd |
Improvements in the stabilisation of biological materials
|
US9309316B2
(en)
*
|
2005-12-20 |
2016-04-12 |
Bristol-Myers Squibb Company |
Stable subcutaneous protein formulations and uses thereof
|
CA2634547C
(en)
*
|
2005-12-20 |
2016-10-11 |
Bristol-Myers Squibb Company |
Stable ctla4 formulation for subcutaneous administration
|
US20090023629A1
(en)
*
|
2005-12-23 |
2009-01-22 |
Altus Pharmaceuticals Inc. |
Compositions comprising polycation-complexed protein crystals and methods of treatment using them
|
DK1989220T3
(da)
|
2006-02-02 |
2012-04-02 |
Trimeris Inc |
HIV-fusionsinhibitorpeptider med forbedrede biologiske egenskaber
|
EP2004753B1
(de)
*
|
2006-03-13 |
2010-01-13 |
NATURIN GmbH & CO. |
Kollagenpulver und auf kollagen basierende thermoplastische zusammensetzung zur herstellung von formkörpern
|
ES2422864T3
(es)
|
2006-08-09 |
2013-09-16 |
Intarcia Therapeutics, Inc |
Sistemas de liberación osmótica y unidades de pistón
|
WO2008118133A2
(en)
|
2006-09-26 |
2008-10-02 |
Trustees Of Tufts College |
Silk microspheres for encapsulation and controlled release
|
US8946200B2
(en)
*
|
2006-11-02 |
2015-02-03 |
Southwest Research Institute |
Pharmaceutically active nanosuspensions
|
AU2007234612B2
(en)
*
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
US8071544B2
(en)
*
|
2006-12-18 |
2011-12-06 |
Althea Technologies, Inc. |
Crystallized recombinant human growth factor formulations
|
ATE516814T1
(de)
*
|
2007-02-02 |
2011-08-15 |
Bristol Myers Squibb Co |
10fn3 domain zur behandlung von krankheiten begleitet von unerwünschter angiogenese
|
AU2008214359B2
(en)
|
2007-02-05 |
2014-01-16 |
Apellis Pharmaceuticals, Inc. |
Local complement inhibition for treatment of complement-mediated disorders
|
JP2010523564A
(ja)
*
|
2007-04-03 |
2010-07-15 |
トリメリス,インコーポレーテッド |
抗ウイルス性ペプチド治療薬の送達のための新規製剤
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
JP5628026B2
(ja)
*
|
2007-06-01 |
2014-11-19 |
ノボ・ノルデイスク・エー/エス |
安定した非水性薬学的組成物
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
US8058237B2
(en)
|
2007-08-07 |
2011-11-15 |
Advanced Technologies & Regenerative Medicine, LLC |
Stable composition of GDF-5 and method of storage
|
CN101874038A
(zh)
*
|
2007-09-25 |
2010-10-27 |
特里梅里斯公司 |
治疗性抗-hiv肽的合成方法
|
US8343140B2
(en)
|
2008-02-13 |
2013-01-01 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US8404850B2
(en)
*
|
2008-03-13 |
2013-03-26 |
Southwest Research Institute |
Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
|
DK2910570T3
(en)
|
2008-03-18 |
2017-01-30 |
Novo Nordisk As |
Protease-stabilized acylated insulin analogues.
|
AU2009236459B2
(en)
*
|
2008-04-14 |
2013-07-25 |
Advanced Technologies And Regenerative Medicine, Llc |
Liquid buffered GDF-5 formulations
|
US8722706B2
(en)
*
|
2008-08-15 |
2014-05-13 |
Southwest Research Institute |
Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
|
US8309134B2
(en)
*
|
2008-10-03 |
2012-11-13 |
Southwest Research Institute |
Modified calcium phosphate nanoparticle formation
|
UA106606C2
(uk)
*
|
2009-03-16 |
2014-09-25 |
Родія Оперейшнс |
Стабілізована біоцидна композиція
|
WO2011005381A2
(en)
|
2009-06-01 |
2011-01-13 |
Trustees Of Tufts College |
Vortex-induced silk fibroin gelation for encapsulation and delivery
|
RU2431496C2
(ru)
*
|
2009-09-15 |
2011-10-20 |
Общество С Ограниченной Ответственностью "Герофарм" |
Инъекционная лекарственная форма для лечения острого ишемического инсульта и черепно-мозговой травмы, способ ее изготовления и применение
|
EP3735944A1
(de)
|
2009-09-28 |
2020-11-11 |
Intarcia Therapeutics, Inc. |
Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
|
US9028873B2
(en)
*
|
2010-02-08 |
2015-05-12 |
Southwest Research Institute |
Nanoparticles for drug delivery to the central nervous system
|
SG10201903166PA
(en)
|
2010-03-01 |
2019-05-30 |
Bayer Healthcare Llc |
Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
|
WO2011109691A2
(en)
|
2010-03-05 |
2011-09-09 |
Trustees Of Tufts College |
Silk-based ionomeric compositions
|
GB201004072D0
(en)
|
2010-03-11 |
2010-04-28 |
Turzi Antoine |
Process, tube and device for the preparation of wound healant composition
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
WO2013063284A1
(en)
|
2011-10-25 |
2013-05-02 |
Onclave Therapeutics |
Antibody formulations and methods
|
WO2013096835A1
(en)
*
|
2011-12-23 |
2013-06-27 |
Abbvie Inc. |
Stable protein formulations
|
WO2013112897A1
(en)
|
2012-01-27 |
2013-08-01 |
The Regents Of The University Of California |
Stabilization of biomolecules using sugar polymers
|
CN104364260B
(zh)
|
2012-04-11 |
2017-02-22 |
诺和诺德股份有限公司 |
胰岛素制剂
|
WO2014035798A1
(en)
|
2012-08-30 |
2014-03-06 |
Sanofi |
Silk lyogels for sustained release of protein therapeutics and methods of making and uses
|
US8613919B1
(en)
|
2012-08-31 |
2013-12-24 |
Bayer Healthcare, Llc |
High concentration antibody and protein formulations
|
US9592297B2
(en)
|
2012-08-31 |
2017-03-14 |
Bayer Healthcare Llc |
Antibody and protein formulations
|
EP3138575B1
(de)
*
|
2014-04-28 |
2021-07-14 |
Eisai R&D Management Co., Ltd. |
Herstellung von gefriergetrocknetem hgf
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
EP4278996A3
(de)
|
2015-06-03 |
2024-01-24 |
i2o Therapeutics, Inc. |
Systeme zum einsetzen eines implantats
|
WO2017104759A1
(ja)
*
|
2015-12-16 |
2017-06-22 |
株式会社 資生堂 |
タブレット型凍結乾燥化粧料
|
MX2018010283A
(es)
|
2016-03-17 |
2019-01-31 |
Eisai R&D Man Co Ltd |
Metodo para producir factor de crecimiento de hepatocitos (hgf) activo.
|
AU2017268161B2
(en)
|
2016-05-16 |
2020-03-12 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
CA3031097A1
(en)
*
|
2016-07-18 |
2018-01-25 |
Tissuegen, Inc. |
Methods and compositions for maintaining the conformation and structural integrity of biomolecules
|
HUE055231T2
(hu)
|
2016-12-16 |
2021-11-29 |
Novo Nordisk As |
Inzulint tartalmazó gyógyászati készítmények
|
CA3049034A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
JP6404405B1
(ja)
*
|
2017-06-14 |
2018-10-10 |
株式会社 資生堂 |
タブレット型凍結乾燥化粧料
|
US20210145705A1
(en)
*
|
2017-06-19 |
2021-05-20 |
Shiseido Company, Ltd. |
Tablet-type freeze-dried cosmetic
|
TWI787186B
(zh)
*
|
2017-06-19 |
2022-12-21 |
日商資生堂股份有限公司 |
錠型凍結乾燥化妝料
|
CN108169499A
(zh)
*
|
2017-11-30 |
2018-06-15 |
成都斯马特科技有限公司 |
一种基于生化试剂盘进行凝血分析的方法
|
BR112021004461A2
(pt)
*
|
2018-09-14 |
2021-05-25 |
Cara Therapeutics, Inc. |
formulações orais de agonistas do receptor opioide kappa
|
WO2020154305A1
(en)
|
2019-01-21 |
2020-07-30 |
Eclipse Medcorp, Llc |
Methods, systems and apparatus for separating components of a biological sample
|
KR20220091580A
(ko)
|
2019-10-31 |
2022-06-30 |
이클립스 메드코프 엘엘씨 |
샘플의 구성요소들을 분리하기 위한 시스템, 방법 및 장치
|
WO2023150580A2
(en)
*
|
2022-02-01 |
2023-08-10 |
Ocular Therapeutix, Inc. |
A controlled release implant for biologics and corresponding methods of treatment
|